Tag: HETLIOZ

All

A court victory forces the Food and Drug Administration to re-examine rejected application for expanded indication.

The FDA has accepted a supplemental new drug application from Vanda Pharmaceuticals for Hetlioz (tasimelteon) in insomnia.